Pfizer, Moderna seen reaping billions from COVID-19 vaccine booster market

  • 3 years ago
Drugmakers Pfizer, BioNTech and Moderna are expected to reap billions of dollars from COVID-19 booster shots in a market that could rival the $6 billion in annual sales for flu vaccines for years to come, analysts and healthcare investors say.

Recommended